Pharmac Put Maori and Pacific Patients First
Lynne Chepulis Associate Professor Health Sciences University of Waikato The controversial 2021 decision by the government drug-buying agency Pharmac to prioritise Maori and Pacific patients in its funding of two game-changing new diabetes drugs appears to have paid off. At the time, Pharmac wanted to restrict funding to